Detalhe da pesquisa
1.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354090
2.
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
Ann Hematol
; 101(6): 1275-1282, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318505
3.
Hemoglobin levels and circulating blasts are two easily evaluable diagnostic parameters highly predictive of leukemic transformation in primary myelofibrosis.
Leuk Res
; 39(3): 314-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636356